Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative treatment for patients with myeloid malignancies such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). However, relapse and graft-versus-host disease (GvHD) still affect the survival of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Guancui, Wang, Xiang, Huang, Shiqin, Huang, Ruihao, Wei, Jin, Wang, Xiaoqi, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577610/
https://www.ncbi.nlm.nih.gov/pubmed/36268012
http://dx.doi.org/10.3389/fimmu.2022.1034438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577610/
https://www.ncbi.nlm.nih.gov/pubmed/36268012
http://dx.doi.org/10.3389/fimmu.2022.1034438

Ejemplares similares